Drugs for Agoraphobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 31)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
2 |
|
Methylphenidate |
Approved, Investigational |
Phase 4 |
|
113-45-1 |
4158 |
Synonyms:
4311/B Ciba
alpha-Phenyl-2-piperidineacetate methyl ester
alpha-Phenyl-2-piperidineacetic acid methyl ester
a-Phenyl-2-piperidineacetate methyl ester
a-Phenyl-2-piperidineacetic acid methyl ester
Calocain
Celltech brand OF methylphenidate hydrochloride
Centedein
Centedrin
Centedrine
Centredin
Cephalon brand OF methylphenidate hydrochloride
Concerta
Concerta®|Jornay PM® (a.k.a. HLD200)|Ritalin®
COTEMPLA XR-ODT
Daytrana
D-Methylphenidate HCL
Equasym
Focalin
Focalin XR
Hydrochloride, methylphenidate
Mallinckrodt brand OF methylphenidate hydrochloride
Meridil
Metadate
Metadate CD
Metadate ER
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl alpha-phenyl-alpha-2-piperidinylacetic acid
Methyl a-phenyl-a-(2-piperidyl)acetate
Methyl a-phenyl-a-(2-piperidyl)acetic acid
Methyl a-phenyl-a-2-piperidinylacetate
Methyl a-phenyl-a-2-piperidinylacetic acid
Methyl phenidyl acetate
Methyl phenidylacetate
Methyl phenidylacetic acid
methyl phenyl(piperidin-2-yl)acetate
Methyl phenyl(piperidin-2-yl)acetic acid
|
Methyl α-phenyl-α-(2-piperidyl)acetate
Methyl α-phenyl-α-(2-piperidyl)acetic acid
Methyl α-phenyl-α-2-piperidinylacetate
Methyl α-phenyl-α-2-piperidinylacetic acid
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate HCL
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidic acid
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MPH
Novartis brand 1 OF methylphenidate hydrochloride
Novartis brand 2 OF methylphenidate hydrochloride
Phenidylate
Plimasine
PMS-Methylphenidate
Riphenidate
Ritalin
Ritalin hydrochloride
Ritalin LA
Ritalin SR
Ritaline
Ritalin-SR
Ritcher Works
Tsentedrin
Α-phenyl-2-piperidineacetate methyl ester
Α-phenyl-2-piperidineacetic acid methyl ester
|
|
3 |
|
Paroxetine |
Approved, Investigational |
Phase 4 |
|
61869-08-7 |
43815 |
Synonyms:
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(−)-(3S,4R)-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BRL-29060
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
Hydrochloride, paroxetine
Maleate, paroxetine
Paroxetina
Paroxetina [INN-Spanish]
PAROXETINE
Paroxetine acetate
|
Paroxetine Hcl
Paroxetine hydrochloride
paroxetine hydrochloride (anhydrous or hemihydrate)|Paxil®|Seroxat®
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxil
PAXIL [AS HYDROCHLORIDE]
Paxil CR
PEXEVA
Seroxat
Seroxat CR
|
|
4 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Antelepsin
Chlonazepam
CLONAZEPAM
CLONAZEPAM CIV
Clonazepam fine granules
Clonazepam tablets
|
Clonazepamum
Klonopin
KLONOPIN RAPIDLY DISINTEGRATING
Klonopin®|Ro-5-4023|Ro-54023
NSC-179913
Rivotril
RO-54023
RO-5-4023
RO-5423
|
|
5 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-32-7, 59729-33-8 |
2771 |
Synonyms:
[<sup>3</sup>H]-citalopram
Akarin
Bonitrile
Celapram
Celexa
Celexa®|Cipramil®|LU-10171B
Celius
Ciazil
Cilift
Cipram
CIPRAMIL
Ciprapine
Citabax
Citadur
Citalec
Citalopram
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
Citol
Citopam
Citox
|
Citrol
Cytalopram
Dalsan
Elopram
Escitalopram
Escitalopram oxalate
Humorup
Lexapro
LU 10-171-B
LU-10-171-B
Nitalapram
Oropram
PAXORAN
Pramcit
Recital
Seropram
Talam
Talohexal
Temperax
Vodelax
Zentius
Zetalo
|
|
6 |
|
Sertraline |
Approved |
Phase 4 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
Altruline
Apo sertraline
Apo-sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
Boehringer ingelheim brand OF sertraline hydrochloride
cis-(+)-Sertraline
CP 51974
CP-519741
CP-51974-1
CP-51974-1|CP-519741|Lustral®|Zoloft®
Esteve brand OF sertraline hydrochloride
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
Hydrochloride, sertraline
Lacer brand OF sertraline hydrochloride
Lustral
|
Novo sertraline
Novopharm brand OF sertraline hydrochloride
Novo-sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Ratio sertraline
Ratiopharm brand OF sertraline hydrochloride
Ratio-sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
SERTRALINE
Sertraline hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
Sultamicillin Tosylate
Zoloft
|
|
7 |
|
Dexetimide |
Withdrawn |
Phase 4 |
|
21888-98-2 |
30843 |
Synonyms:
(+)-BENZETIMIDE
(+)-benzetimide|R 16470|Tremblex®
Dexetimida
DEXETIMIDE
|
Dexetimidum
R 16470
R-16470 [AS HYDROCHLORIDE]
TREMBLEX
|
|
8 |
|
Central Nervous System Stimulants |
|
Phase 4 |
|
|
|
9 |
|
Dopamine Uptake Inhibitors |
|
Phase 4 |
|
|
|
10 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
11 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
12 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
13 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
14 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
15 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
16 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
17 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
18 |
|
Lecithin |
Approved, Experimental, Investigational, Nutraceutical |
Phase 3 |
|
8002-43-5, 1446756-47-3, 18656-38-7 |
26197 9547096 6323481 |
Synonyms:
(1)-(7-Myristoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphatricosyl)trimethylammonium 4-oxide
(2S)-2-Amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoate
[2-({[2,3-bis(tetradecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium
1,2 Dimyristoyl glycero 3 phosphorylcholine
1,2 Ditetradecanoyl glycero 3 phosphocholine
1,2 Ditetradecyl glycero 3 phosphocholine
1,2-Dimyristoyl-glycero-3-phosphorylcholine
1,2-Dimyristoyl-sn-glycero-3-phosphatidylcholine
1,2-Dioctadecanoyl-rac-glycero-3-phosphoserine
1,2-Dioctadecanoyl-sn-glycero-3-phosphoserine
1,2-Distearoyl-rac-glycero-3-phosphoserine
1,2-Ditetradecanoyl-glycero-3-phosphocholine
1,2-Ditetradecanoyl-sn-glycero-3-phosphocholine
1,2-Ditetradecyl-glycero-3-phosphocholine
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate
2,3-Bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphoric acid
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
3-O-sn-Phosphatidyl-L-serine
Acetylglucosamine
D-GlcNAc
dimyristoyl phosphatidylcholine
Dimyristoyllecithin
|
Dimyristoylphosphatidylcholine
Dimyristoyl-phosphatidylcholine
Distearoyl phosphatidylserine
distearoylphosphatidylserine|PS
DMCP
DMPC
Lecithins
l-α-dimyristoylphosphatidylcholine
N Acetyl D glucosamine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
O3-Phosphatidyl-L-serine
Phosphatidyl serine
Phosphatidylcholine
Phosphatidyl-L-serine
Phosphatidylserine
Phosphatidylserine(18:0/18:0)
Phosphatidylserine(36:0)
Phospholutein
PS
PS(18:0/18:0)
PS(36:0)
pSer(18:0/18:0)
pSer(36:0)
|
|
19 |
|
Anticonvulsants |
|
Phase 3 |
|
|
|
20 |
|
Sunflower |
|
Phase 3 |
|
|
|
21 |
|
Cycloserine |
Approved |
Phase 2 |
|
68-41-7 |
6234 |
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-AMINOISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
ABBR DCS
a-Cycloserine
alpha-Cycloserine
Cicloserina
Cyclo-D-serine
CYCLOSERINE
Cyclosérine
Cycloserinum
D-(+)-Cycloserine
D-4-Amino-3-isoxazolidinone
D-4-Amino-3-isoxazolidone
DCS
D-CS
|
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
DL-Cycloserine
D-Oxamicina
D-Oxamycin
L-Cycloserine
NSC-154851
NSC-76029
Orientomycin
PA 94
PA-94
R-4-Amino-3-isoxazolidinone
Ro-1-9213
Seromycin
Α-cycloserine
|
|
22 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
23 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
24 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
25 |
|
Antitubercular Agents |
|
Phase 2 |
|
|
|
26 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
27 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
28 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
29 |
|
Magnesium sulfate |
Approved, Investigational, Vet_approved |
|
|
7487-88-9 |
|
Synonyms:
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulphate
|
magnesium(II) sulfate
Magnesiumsulfat
MgSO4
|
|
30 |
|
Nicotine |
Approved |
|
|
54-11-5 |
942 89594 |
Synonyms:
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(−)-nicotine
(-)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+)-Nicotine
(+-)-Nicotine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(RS)-Nicotine
(S)-(−)-nicotine
(S)-(-)-Nicotine
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine
(S)-3-(N-Methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridal)-pyrrolidine
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-Methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
a -N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
a-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
Bitartrate, nicotine
Black Leaf
Black Leaf 40
Campbell's Nico-Soap
Commit
delta-Nicotine
Destruxol
Destruxol Orchid Spray
DL-Tetrahydronicotyrine
D-Nicotine
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
Habitrol
L(−)-nicotine
L(-)-Nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
|
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Niagara P.A. Dust
NICABATE
Nicocide
Nicoderm
NICODERM CQ
Nico-Dust
Nico-Fume
NICOPASS
NICOPATCH
Nicorette
NICORETTE INVISI
Nicorette Plus
Nicorette®|Nicotrol®
Nicotin
Nicotina
Nicotine
Nicotine alkaloid
Nicotine betadex
Nicotine bitartrate
Nicotine polacrilex
Nicotine tartrate
NICOTINELL CLASSIC
NICOTINELL SUPPORT
NICOTINELL TTS 10
NICOTINELL TTS 20
NICOTINELL TTS 30
NICOTROL
NICOTROL INHALER
NICOTROL NS
Nic-Sal
Nikotin
Nikotyna
NIQUITIN
NIQUITIN CLR
NIQUITIN MINIS CHERRY
NIQUITIN MINIS MINT
NIQUITIN MINIS ORANGE
NIQUITIN MINT
NIQUITIN PRE-QUIT
NIQUITIN STRIPS MINT
Ortho N-4 Dust
Ortho N-5 Dust
PROSTEP
R)-(+)-Nicotine
STOPPERS
STUBIT
Tartrate, nicotine
Tendust
|
|
31 |
|
Pharmaceutical Solutions |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 55)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity |
Unknown status |
NCT03785223 |
Phase 4 |
Methylphenidate Hydrochloride Controlled-Release Capsules;Placebo Capsule |
2 |
Long-term, Open, Naturalistic, Randomized Clinical Trial With Clonazepam and Paroxetine in Panic Disorder With or Without Agoraphobia |
Completed |
NCT02852577 |
Phase 4 |
Clonazepam;Paroxetine |
3 |
Comparative Effectiveness of Mindfulness-Based Stress Reduction and Pharmacotherapy for Anxiety |
Completed |
NCT03522844 |
Phase 4 |
Escitalopram |
4 |
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity |
Terminated |
NCT00182533 |
Phase 4 |
Sertraline;Placebo |
5 |
Mechanisms of CBT-Treatment Effects in Patients With Panic Disorder and Panic Disorder With Agoraphobia: The Role of Interoceptive Exposure |
Unknown status |
NCT01323556 |
Phase 2, Phase 3 |
|
6 |
Dynamic Treatment vs. CBT for Panic Disorder |
Completed |
NCT00353470 |
Phase 3 |
|
7 |
Treatment of Panic Disorder: Long Term Strategies |
Completed |
NCT00000368 |
Phase 3 |
Paroxetine or other medication - algorithm used |
8 |
Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder: Comparison of Therapist-Led and Therapist Assisted Approaches |
Recruiting |
NCT04922502 |
Phase 2, Phase 3 |
|
9 |
Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study |
Not yet recruiting |
NCT03549819 |
Phase 3 |
Cannabidiol (CBD) Oil Capsules;Sunflower Lecithin Oil in Capsule |
10 |
Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study |
Withdrawn |
NCT04569760 |
Phase 3 |
50:2 mg(CBD:THC)/ml - Cannabinoid Oil Oral Preparation- titrated as tolerated up to a maximum 8mls twice daily (200 mg- 800 mg total dose);Placebo Oil |
11 |
Augmentation of Exposure Therapy With D-Cycloserine in Patients With Agoraphobia With or Without Panic Disorder |
Completed |
NCT01928823 |
Phase 2 |
D-Cycloserine |
12 |
Intensive Treatment of Adolescent Panic and Agoraphobia |
Completed |
NCT00576719 |
Phase 2 |
|
13 |
The Modular Protocol for Mental Health (MPMH): A Pilot Randomised Clinical Trial of a Transdiagnostic Psychological Treatment for Mood and Anxiety Disorders in Adults |
Completed |
NCT03143634 |
Phase 1, Phase 2 |
|
14 |
Construction of a Questionnaire on Panic Disorder and Agoraphobia |
Unknown status |
NCT03885453 |
|
|
15 |
A Comparative Controlled Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia |
Unknown status |
NCT00129610 |
|
|
16 |
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli |
Unknown status |
NCT03206437 |
|
|
17 |
Exposure Initializes Therapy - Treatment Of Homebound Patients Extended |
Unknown status |
NCT04460378 |
|
|
18 |
Effect of Cognitive-behavior Therapy on Panic Symptomatology and the Activation of the Brain's Fear Network to Panic-related Body Symptoms in Patients With Panic Disorder |
Completed |
NCT04568109 |
|
|
19 |
Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder: A Pragmatic, Multicenter Non-inferiority Randomized Controlled Trial |
Completed |
NCT02954731 |
|
|
20 |
Efficacy of Hypnotherapy Compared to a Wait-list Control Group in the Treatment of Agoraphobia |
Completed |
NCT03684577 |
|
|
21 |
Evaluation of Occupational Balance, Fear and Agoraphobia in Adults |
Completed |
NCT04681261 |
|
|
22 |
Effectiveness of Specific Model of Cognitive-Behavioral Therapy in Panic Disorder Patients With Agoraphobia |
Completed |
NCT00772746 |
|
|
23 |
The Influence of Physical Activity (Prior to In-vivo Exposure) on the Effect of Cognitive Behavioural Therapy in Patients With Panic Disorder and Agoraphobia |
Completed |
NCT01928810 |
|
|
24 |
Virtual Reality for Panic Disorder With Agoraphobia: a Clinical Trial |
Completed |
NCT03101332 |
|
|
25 |
Moderators and Mediators of Treatment Change in Panic Disorder and Agoraphobia |
Completed |
NCT03547180 |
|
|
26 |
Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia |
Completed |
NCT00004367 |
|
|
27 |
Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy |
Completed |
NCT00932919 |
|
|
28 |
The Influence of Physical Activity on the Effect of Cognitive Behavioural Therapy, Neurobiological Parameters and Information Processing in Patients With Panic Disorder With/Without Agoraphobia |
Completed |
NCT01788800 |
|
|
29 |
Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Panic Disroder and Agoraphobia |
Completed |
NCT01446172 |
|
|
30 |
Internet-based Exposure Therapy for Panic Disorder: A Randomized Controlled Pilot Study |
Completed |
NCT03061448 |
|
|
31 |
Examining the Effects of Reduced Environmental Stimulation on Anxiety |
Completed |
NCT03051074 |
|
|
32 |
Predicting Treatment Response to Exposure Therapy Using a CO2 Habituation Paradigm in Patients With High Levels of Anxiety Sensitivity |
Completed |
NCT03925987 |
|
|
33 |
Providing Tools for Effective Care and Treatment of Anxiety Disorders (AD): Outcomes, Mediators and Moderators of Enhanced Extinction |
Completed |
NCT02605668 |
|
|
34 |
Virtual Reality Exposure Therapy in Agoraphobic Participants |
Completed |
NCT00734370 |
|
|
35 |
Phase 2/3 Study of Panic Control Treatment vs Panic-Focussed Psychodynamic Psychotherapy Under Randomized and Self-Selection Conditions |
Completed |
NCT01606592 |
|
|
36 |
Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety |
Completed |
NCT02810171 |
|
|
37 |
Cognitive-behavioural Therapyin Panic Disorder: the Preparation of Patients With Panic Disorder for Interoceptive and in Vivo Agoraphobic Exposure |
Completed |
NCT01025908 |
|
|
38 |
Improving Access to Treatment of Anxiety and Depression in Young Adults Using Transdignostic iCBT: Feasibility of a Translated Version of an Empirically Supported Program |
Completed |
NCT03156556 |
|
|
39 |
Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group. |
Completed |
NCT00202709 |
|
|
40 |
Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction |
Completed |
NCT00004366 |
|
|
41 |
A Pragmatic Randomized Controlled Trial of Group Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders in Primary Care |
Completed |
NCT02811458 |
|
|
42 |
Effectiveness of Cognitive Behavioral Short-term Treatment for Adolescents With Emotional Symptom Problems in Community Clinics in Norway. A Randomized Controlled Study |
Completed |
NCT02150265 |
|
|
43 |
The Effect of a Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders |
Recruiting |
NCT04793828 |
|
|
44 |
Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia |
Recruiting |
NCT01680237 |
|
|
45 |
Ambulante Leitlinienkonforme Intervention im Selbstmanagement für Angststörungen (ALISA) |
Recruiting |
NCT05510804 |
|
|
46 |
Building an Outcomes Assessment Infrastructure to Assess Youth in the McLean Anxiety Mastery Program at McLean Hospital |
Recruiting |
NCT02305537 |
|
|
47 |
SoREAL- a Randomized Clinical Trial |
Recruiting |
NCT03845101 |
|
|
48 |
A Comparison of the Efficacy of Transdiagnostic Behavior Therapy and Disorder-specific Therapy in Veterans With PTSD, Anxiety, and Depression |
Recruiting |
NCT04293341 |
|
|
49 |
Comparison of Patient-Centered Versus Provider-Centered Delivery of Cognitive Behavioral Treatment (CBT) for Pediatric Anxiety and Obsessive Compulsive Disorder (OCD) |
Recruiting |
NCT03528109 |
|
|
50 |
Respiratory Training vs Interoceptive Exposure in the Treatment of Transdiagnostic Pathological Anxiety: A Randomized Clinical Trial |
Recruiting |
NCT05427708 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Cochrane evidence based reviews: agoraphobia
|